Soumit Roy
Stock Analyst at Jones Trading
(3.00)
# 1,556
Out of 5,182 analysts
44
Total ratings
34.29%
Success rate
17.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine | Upgrades: Buy | $8 | $3.00 | +166.67% | 2 | Mar 10, 2026 | |
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $4.01 | +74.56% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $2.36 | +196.61% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $4.41 | +126.76% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $3.34 | - | 1 | Oct 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Hold | n/a | $0.81 | - | 2 | Sep 15, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $66.74 | -25.08% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $5.33 | +294.00% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $31.09 | +28.66% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $41.23 | -34.51% | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.85 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.88 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $3.69 | +306.50% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.45 | +124.72% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $30.33 | +12.10% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $1.47 | +2,348.98% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $5.27 | +507.21% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $10.55 | -14.69% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $9.88 | +72.06% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $7.55 | +747.68% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.80 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $13.05 | +99.23% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $14.37 | +387.13% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $52.15 | -80.82% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.09 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.89 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $0.47 | +67,811.71% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $7.16 | +11,212.85% | 1 | Feb 24, 2021 |
Editas Medicine
Mar 10, 2026
Upgrades: Buy
Price Target: $8
Current: $3.00
Upside: +166.67%
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $4.01
Upside: +74.56%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.36
Upside: +196.61%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.41
Upside: +126.76%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $3.34
Upside: -
aTyr Pharma
Sep 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.81
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $66.74
Upside: -25.08%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $5.33
Upside: +294.00%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $31.09
Upside: +28.66%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $41.23
Upside: -34.51%
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.85
Upside: -
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.88
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $3.69
Upside: +306.50%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $4.45
Upside: +124.72%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $30.33
Upside: +12.10%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $1.47
Upside: +2,348.98%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $5.27
Upside: +507.21%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $10.55
Upside: -14.69%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $9.88
Upside: +72.06%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $7.55
Upside: +747.68%
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.80
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $13.05
Upside: +99.23%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $14.37
Upside: +387.13%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $52.15
Upside: -80.82%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.09
Upside: -
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.89
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $0.47
Upside: +67,811.71%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $7.16
Upside: +11,212.85%